Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Neurology

Can You Have Both MSA-P and MSA-C Subtypes?

At a Glance

Yes, it is very common to have both MSA-P and MSA-C subtypes. While doctors use these labels based on early predominant symptoms, Multiple System Atrophy (MSA) often involves a blend of parkinsonian stiffness and cerebellar balance issues as it progresses.

Yes. While doctors often categorize Multiple System Atrophy (MSA) as either MSA-P or MSA-C, it is very common to experience a mix of symptoms from both subtypes [1][2]. These labels describe which symptoms are the most prominent when you are first diagnosed, rather than creating strict, unchanging boundaries [3][4]. Because MSA affects multiple systems in the brain and body, many people eventually develop a blend of both parkinsonian and cerebellar symptoms as the disease progresses [5][6].

Why Doctors Use Subtypes

When you are first diagnosed with MSA, your care team looks at your primary motor (movement) symptoms to determine your subtype:

  • MSA-P (Parkinsonian): The most noticeable early symptoms are stiffness, slowness of movement, and sometimes tremors [3]. Unlike typical Parkinson’s disease, the stiffness and slowness in MSA-P often do not respond well to standard Parkinson’s medications like levodopa.
  • MSA-C (Cerebellar): The most noticeable early symptoms involve issues with coordination, a wobbly gait, and balance problems [7].

Doctors use these categories because they help describe your most urgent daily challenges and guide your early symptom management strategies [4]. However, recent research shows that MSA is a highly varied disease, and these conventional classifications do not capture everything a patient experiences [5][8].

How Symptoms Mix Over Time

Under the surface, MSA involves physical changes in multiple areas of the brain. The two primary processes are striatonigral degeneration (which causes the parkinsonian stiffness) and olivopontocerebellar atrophy (which causes the cerebellar coordination issues) [4][9].

In many patients, these two processes happen at the same time [10]. Over time, this means the lines between MSA-P and MSA-C often blur:

  • A person originally diagnosed with MSA-P might begin to stumble or notice their speech becoming slurred (cerebellar symptoms).
  • A person originally diagnosed with MSA-C might find their muscles becoming increasingly rigid or their movements slowing down (parkinsonian symptoms).

Because of this overlap, experts increasingly view MSA as a broad spectrum rather than two distinct diseases [5][1]. As new symptoms emerge, your care plan won’t necessarily need a total overhaul; instead, your medical team will adapt your treatments to focus on whichever symptoms are currently affecting your quality of life.

The Shared Symptoms: Autonomic Dysfunction and Sleep

Whether your medical file says MSA-P or MSA-C, all diagnosed patients experience a core group of symptoms known as autonomic dysfunction [2][11]. The autonomic nervous system controls automatic body functions, and its failure is a strict requirement for an MSA diagnosis [3].

Key shared autonomic symptoms include:

  • Orthostatic hypotension: A sharp drop in blood pressure when standing up, which can cause severe lightheadedness or fainting [2].
  • Urinary dysfunction: Trouble holding urine or fully emptying the bladder [3].

These autonomic features are a defining hallmark of MSA, connecting the P and C subtypes into a single, unified diagnosis [12][13]. Additionally, many people with both subtypes experience REM Sleep Behavior Disorder (RBD), where they act out vivid dreams during sleep. This is extremely common and can precede motor symptoms by years.

Common questions in this guide

Can you have symptoms of both MSA-P and MSA-C at the same time?
Yes, it is extremely common to experience a mix of both parkinsonian (MSA-P) and cerebellar (MSA-C) symptoms. While doctors use these labels to describe your initial symptoms, the disease often blends over time as changes occur in multiple brain areas.
Why do doctors categorize MSA into P and C subtypes?
Doctors use these subtypes based on your primary movement symptoms when first diagnosed. This helps them understand your most urgent daily challenges and guides your early symptom management strategies.
Will my MSA symptoms change from one subtype to another?
Yes, MSA is a broad spectrum, and symptoms frequently evolve. A person starting with MSA-P stiffness might develop MSA-C balance issues later, or vice versa.
What symptoms do all MSA subtypes share?
Regardless of your subtype, all MSA diagnoses require autonomic dysfunction. This includes symptoms like a sharp drop in blood pressure when standing (orthostatic hypotension) and bladder control issues.
How does having mixed MSA symptoms affect my treatment plan?
As new symptoms emerge, your care team will adapt your treatments and physical therapy to focus on the issues currently affecting your quality of life. You won't necessarily need a total overhaul of your care plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given my current mix of symptoms, should we adjust my physical therapy or medication plan to address my new balance issues or stiffness?
  2. 2.What specific autonomic symptoms, such as blood pressure drops or bladder issues, should I be prioritizing and tracking most closely right now?
  3. 3.Since my symptoms don't perfectly fit just one subtype anymore, who are the most important specialists I need on my care team?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Nature of Parkinsonian features in multiple system atrophy.

    Pradhan S, Tandon R

    Journal of neurosciences in rural practice 2024; (15(2)):211-216 doi:10.25259/JNRP_445_2023.

    PMID: 38746510
  2. 2

    Is There a Difference in Autonomic Dysfunction Between Multiple System Atrophy Subtypes?

    Garg D, Srivastava AK, Jaryal AK, et al.

    Movement disorders clinical practice 2020; (7(4)):405-412 doi:10.1002/mdc3.12936.

    PMID: 32373657
  3. 3

    "One line": A method for differential diagnosis of parkinsonian syndromes.

    Sako W, Abe T, Haji S, et al.

    Acta neurologica Scandinavica 2019; (140(3)):229-235 doi:10.1111/ane.13136.

    PMID: 31225648
  4. 4

    A historical review of multiple system atrophy with a critical appraisal of cellular and animal models.

    Marmion DJ, Peelaerts W, Kordower JH

    Journal of neural transmission (Vienna, Austria : 1996) 2021; (128(10)):1507-1527 doi:10.1007/s00702-021-02419-8.

    PMID: 34613484
  5. 5

    Data-driven subtype classification of patients with early-stage multiple system atrophy.

    Yang HJ, Kim HJ, Jung YJ, et al.

    Parkinsonism & related disorders 2022; (95()):92-97 doi:10.1016/j.parkreldis.2022.01.009.

    PMID: 35065515
  6. 6

    An update on MSA: premotor and non-motor features open a window of opportunities for early diagnosis and intervention.

    Chelban V, Catereniuc D, Aftene D, et al.

    Journal of neurology 2020; (267(9)):2754-2770 doi:10.1007/s00415-020-09881-6.

    PMID: 32436100
  7. 7

    Epigallocatechin gallate in multiple system atrophy (PROMESA).

    Jellinger KA

    Annals of translational medicine 2019; (7(Suppl 8)):S278 doi:10.21037/atm.2019.11.141.

    PMID: 32015997
  8. 8

    Nonmotor Features in Atypical Parkinsonism.

    Bhatia KP, Stamelou M

    International review of neurobiology 2017; (134()):1285-1301 doi:10.1016/bs.irn.2017.06.001.

    PMID: 28805573
  9. 9

    Quantitative cellular changes in multiple system atrophy brains.

    Andersen AM, Kaalund SS, Marner L, et al.

    Neuropathology and applied neurobiology 2023; (49(6)):e12941 doi:10.1111/nan.12941.

    PMID: 37812040
  10. 10

    Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy.

    Lin J, Xu X, Hou Y, et al.

    Frontiers in aging neuroscience 2020; (12()):591666 doi:10.3389/fnagi.2020.591666.

    PMID: 33328969
  11. 11

    Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study.

    Miki Y, Foti SC, Asi YT, et al.

    Brain : a journal of neurology 2019; (142(9)):2813-2827 doi:10.1093/brain/awz189.

    PMID: 31289815
  12. 12

    Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes.

    Zhang L, Cao B, Ou R, et al.

    Parkinsonism & related disorders 2017; (35()):63-68 doi:10.1016/j.parkreldis.2016.12.007.

    PMID: 27993522
  13. 13

    Anhidrosis in multiple system atrophy involves pre- and postganglionic sudomotor dysfunction.

    Coon EA, Fealey RD, Sletten DM, et al.

    Movement disorders : official journal of the Movement Disorder Society 2017; (32(3)):397-404 doi:10.1002/mds.26864.

    PMID: 27859565

This page explains Multiple System Atrophy subtypes and symptoms for educational purposes only. Always consult your neurologist or care team about your specific symptoms, diagnosis, and treatment plan.

Get notified when new evidence is published on Multiple system atrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.